Accel Frontline Ltd. has announced that it has inked an Memorandum Of Understanding (MoU) with a US-based SciGenom Labs for delivering value added software development and cloud computing services for the Life Sciences Sector.
Under the MoU, Accel will get access to new areas in key markets, like the US, Japan, etc. in the areas of life sciences, healthcare and Government institutions.
At present, Accel s software unit concentrates on vertical industry segments like BFSI, telecom, ISV s and consumer electronics in the regions of product engineering and R&D services, application development, lifecycle management and managed services.
Through this tie up Accel will expand its services into Life Sciences, leveraging SciGenom s expertise. We are excited about the opportunity to partner with SciGenom in contributing to the future expansion of the life sciences market through value added IT software development services, said Accel CEO N.R. Panicker.
SciGenom over the last few years has created a strong domain expertise in genomic sequencing and molecular testing services to life science and healthcare businesses. This new tie up with Accel will enable SciGenom to offer value-added software development services and product implementation to its existing customers. Accel s expertise in mobile user interface development and embedded technologies will be a great benefit to SciGenom s customers, said SciGenom Labs Founder and CEO Sam Santhosh.